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Summary
In recent years it has become clear that carbohydrate portions of glycoconjugates are
performing numerous vital physiological functions in higher organisms. However, since
glycobiology is a relatively new science, and carbohydrate structures are highly complex,
the continuous development of novel analytical techniques is necessary to support the
process of understanding the intricate nature of glycoconjugate structure and function.
The introduction of digoxin as a novel tag for labelling of lectins that are being used to
analyse glycoconjugates in immunoassay-like techniques is described. Lectins labelled
with digoxin have significant advantages over biotin- or digoxigenin-labelled lectins and
will hopefully prove to be a useful addition to the repertoire of glycobiological tools.
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Introduction
Nearly all membrane proteins are either glycosy-
lated, or in complex with other glycosylated proteins (1).
Over a half of all proteins contain N-linked oligosaccha-
rides (2), and other forms of glycosylation are also very
abundant (3). Extensive research conducted during the
past years clearly demonstrated the importance of car-
bohydrate portions of glycoconjugates in numerous vital
physiological processes, and today it is generally accep-
ted that these processes can not be fully understood
without knowing the structure of both protein and car-
bohydrate parts of the involved molecules (4).
Plant lectins are a simple and versatile tool to ana-
lyse glycoconjugates (5). They can be used in a number
of immunoassay-like techniques including ELLA (en-
zyme-linked lectin assay), lectin-western blot or lectin
affinity chromatography. However, in contrast with an-
tibodies, lectins do not share common structural fea-
tures, thus there are no universal secondary antibodies
to lectins. In order to be used in immunoassay-like tech-
niques lectins have to be first labelled with a suitable
tag that will enable their subsequent identification and
detection. Most frequently used tags today are biotin
and digoxigenin and here we describe the introduction
of digoxin as a novel tag to label lectins.
Materials and Methods
Digoxin and CNBr were purchased from Aldrich
Chem. Co. (Milwaukee, WI), 5-bromo-4-chloro-3-indolyl
phosphate (BCIP), nitro-blue tetrazolium (NBT), Conca-
navaline A and anti-digoxin monoclonal antibodies la-
belled with alkaline phosphatase from Sigma (St. Louis,
MO), PVDF membranes were obtained from Millipore
(Bedford, MA). Concanavaline A, WGA and SNA lectins
labelled with biotin were purchased from Vector Labo-
ratories (Burlingame, CA).
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Thin-layer chromatography
Thin-layer chromatography (TLC) was performed
on 0.2 mm Silica Gel 60 F254 precoated on aluminum
sheets (Merck, Darmstadt, Germany). Chloroform:meth-
anol:water (80:20:1, volume fractions) solvent system
was used for development and digoxin was detected by
»charring« after spraying with 15 % H2SO4 in 80 % etha-
nol.
Activation of digoxin using CNBr
Digoxin (100 mol) was dissolved to a final concen-
tration of 33 mM in 33 % tetrahydrofuran, 66 % 2 M
K-phosphate buffer (pH=12) to form a biphasic mixture.
CNBr (10-fold excess) was added to the mixture as 5 M
solution in tetrahydrofuran. Reaction mixture was stir-
red at room temperature for 30–60 min, and the forma-
tion of the product was monitored by thin-layer chro-
matography. »Activated« digoxin appeared as a major
product with Rf slightly lower than digoxin. The esti-
mated product yield was usually 40–60 %. If CNBr was
excluded from the reaction mixture, TLC analysis re-
vealed no change in digoxin within 60 min of the reac-
tion, suggesting unusual stability of the lactone ring to
alkaline conditions.
The reaction mixture was evaporated under re-
duced pressure, and the dried powder was redissolved
in 20 mL mixture of chloroform and 1 M NaCl (1:1, vol-
ume fractions). After vigorous shaking, the phases were
separated and the water phase was extracted with addi-
tional 10 mL chloroform. Virtually all digoxin was found
in the combined chloroform phases. The combined chlo-
roform phases were briefly washed with 5 mL water to
remove any residual water-soluble material, and dried
under reduced pressure. A significant amount of un-
reacted digoxin remained with the "activated" digoxin,
but no steps were performed to remove it since it does
not interfere with the subsequent reaction steps. If stored
dry, the ratio of "activated digoxin" to digoxin remained
constant for months at room temperature.
Labelling of Concanavaline A with digoxin
Pure Concanavaline A (2 mg) was dissolved in 1
mL 50 mM Na-carbonate buffer, pH=9.5 and dialysed
against 2 x 1 L of the same buffer at +4 C. CNBr-acti-
vated digoxin (2 mol) was dissolved in 200 L metha-
nol and rapidly mixed with Concanavaline A solution.
After overnight incubation at room temperature, 2 mol
of glycine was added to inactivate any remaining CNBr-
-activated digoxin. The reaction mixture was dialysed
against three 1000 mL changes of 10 mM Na-phosphate
buffer, pH=7.5 at +4 C and freeze dried.
Cell and tissue sample preparation
Male Fischer rat was sacrificed and liver, spleen,
thymus, cortex and serum were removed. The tissues
were homogenised in 10 volumes of ice-cold homogeni-
sation buffer (50 mM Tris buffer, pH=6.5, containing 150
mM NaCl, 5 mM EDTA, 1 mM PMSF, 1 % Triton X-100)
and protease inhibitors (Sigma, Ca. #P2714), using a Tef-
lon homogeniser. The protein concentration of the sam-
ples was determined by the BCA method (6).
HL60 cells were collected, washed with PBS and
lysed by sonication in 1 % Triton X-100, 15 mM NaCl, 5
mM Tris/HCl, pH= 8.0.
Electrophoresis and blotting
Proteins were separated electrophoretically in 12 %
SDS-polyacrylamide slab gels as described by Laemmli
(7). After electrophoresis, proteins were transferred onto
Immobilon PVDF membrane in a semi-dry apparatus
according to Towbin (8). Blotting membranes were
blocked overnight with 3 % BSA, and incubated in 3 mL
1 g/mL solution of labelled lectins for 60 min. After
washing, blots were developed with anti-digoxin anti-
bodies (for lectins labelled with digoxin) or streptavidin
(for lectins labelled with biotin) conjugated with alkaline
phosphatase and visualised with 0.02 mg/mL BCIP and
0.04 mg/mL NBT in 50 mM Tris/HCl, pH=8.5, 100 mM
NaCl, 5 mM MgCl2.
Results and Discussion
After using biotin- and digoxigenin-labeled lectins
for a number of years (9,10) we have noticed that both,
lectins labelled with biotin and lectins labelled with
digoxigenin, have significant disadvantages. Primary
problem with biotin as a tag is the existence of endoge-
nous biotin in various tissues that can lead to false-posi-
tive staining. To assess this problem we have analysed
rat cortex, thymus, serum, spleen and liver tissues with
streptavidin. As it is clearly shown in Fig. 1A, nearly all
tissues have several proteins that contain covalently
linked biotin and will turn out positive in any assay sys-
tem that uses biotin as a label. This is not surprising
since biotin is a prosthetic group that is covalently linked
to a number of ubiquitously expressed endogenous en-
zymes (for example pyruvate-carboxylase). Since endog-
enous biotin cannot be differentiated from biotin that is
used as a label, all methods that use biotin-containing
conjugates are prone to false-positive results. Sometimes
these proteins can be excluded using appropriate nega-
tive controls, but this is frequently either not convenient,
or even not possible.
An alternative label, which can alleviate the short-
coming of biotin is digoxigenin. Digoxigenin is a
deglycosylated form of the cardiac glycoside, digoxin
(Fig. 2) that has been used as a drug for centuries.
Highly specific and strong-binding monoclonal and
polyclonal antibodies have been developed as an anti-
dote to treat digoxin overdose (11,12). When labelled
with an appropriate enzyme these antibodies can be
used to detect both digoxin and digoxigenin. Digoxige-
nin was first introduced to glycobiology by Boehringer
Mannheim (now Roche Biochemicals), who used it to la-
bel lectins (13). It proved to be an excellent label that
eliminated problems of false positives due to the pres-
ence of endogenous biotin (Fig 1B), but in the recent
years this line of products has been significantly down-
sized and individual digoxigenin-labelled lectins are not
commercially available any more.
While the use of digoxigenin is limited by patents
awarded to Boehringer Mannheim, high acid sensitivity
of the glycosidic bonds between digitoxoses, and the al-
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kaline sensitivity of the lactone ring, impeded chemical
derivatisation and use of its parent compound digoxin
as a label. By using activation with cyanogen bromide
we managed to make digoxin reactive with amino-com-
pounds (14), which enabled us to use it as a tag to label
lectins. The procedure is described in detail in Materials
and Methods section. The actual product is a mixture of
amino-containing compounds linked to 3' or 4' hydroxyl
group on the third digitoxose. We have successfully la-
belled several lectins including those from Sambucus
nigra (SNA), Triticum vulgare (WGA) and Concanavaline
A (ConA).
ConA is one of the most widely used lectins. It has
broad applicability primarily because it recognises a
commonly occurring sugar structure, -linked mannose.
At neutral and alkaline pH, ConA exists as a tetramer of
four identical subunits of approximately 26 000 daltons
(237 amino acid residues) each. »Native« ConA is a mix-
ture of several forms of the lectin due to »nicks« occur-
ring in the polypeptide chains. Although having little or
no effect on the saccharide binding activity, these
»nicks« in the sequence are often revealed even in the
purest lectin preparations as additional bands in SDS-
-polyacrylamide gel electrophoresis. These hydrolytic
cleavage sites appear to exist in the lectin as it occurs in
the seeds and are not a function of isolation procedures.
Concanavaline A was labelled with digoxin as de-
scribed in Materials and Methods section. The proce-
dures for labelling other lectins were very similar, but
since lectins vary significantly in the availability of free
amino groups, solubility and stability, it is necessary to
optimise labelling conditions for each individual lectin.
The addition of a water-miscible organic solvent such as
ethanol, methanol or acetonitrile to final concentration
of 10–30 % is necessary to keep activated digoxin in so-
lution. Depending upon the lectin being labelled, acti-
vated digoxin should be added in 5- to 20-fold molar ex-
cess and incubated overnight. Since too many attached
digoxin molecules can decrease lectin activity, exact ra-
tio of digoxin and lectin concentrations have to be deter-
mined experimentally for each lectin.
The applicability and specificity of digoxin labelled
lectins were verified by comparing it to commercially ob-
tained ConA lectin labelled with biotin in a lectin-west-
ern blot assay. As it is clearly visible in Fig. 3, lectins
that we have labelled with digoxin produced virtually
the same staining patterns as commercially obtained lec-
tins. Beside in lectin western-blot, lectins labelled with
digoxin can also be used in other applications including
histochemistry and enzyme-linked lectin assay (ELLA).
Conclusions
In this paper the introduction of digoxin as a novel
tag to label lectins has been described. Contrary to bio-
tin, digoxin does not exist as a covalently linked cellular
component, and it is thus much more reliable and/or
convenient label. Lectins labelled with digoxin can be
easily prepared in any laboratory, and since they can be
used interchangeably with digoxigenin-labelled lectins,

























Fig. 2. Structure of Digoxin
Fig. 1. Endogenous biotin in rat tissues. Homogenates (10 g
protein per lane) of rat cortex (1), thymus (2), serum (3), spleen
(4) and liver (5) were separated by reducing SDS-PAGE, blotted
onto PVDF membrane and developed with streptavidine-biotin-
ylated alkaline phosphatase complex (panel A) or anti-digoxin
antibody labelled with alkaline phosphatase (panel B).
Fig. 3. Glycosylation of analysis of HL60 cells. HL60 cell homo-
genates were separated by SDS-PAGE (5 g total protein per
lane) and stained with ConA labelled with biotin (A), ConA la-
belled with digoxin (B), WGA labelled with biotin (C), WGA la-
belled with digoxin (D), SNA labelled with biotin (E), or SNA
labelled with digoxin (F). Antibodies against digoxin or strepta-
vidin labelled with alkaline phosphatase were used to detect di-
goxin and biotin, and the complex was visualised with BCIP/
NBT, as described in Materials and Methods section.
and detected with antibodies against digoxin or digoxi-
genin, hopefully they will help to fill the current gap in
the availability of reliable labelled lectins.
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Digoksinom ozna~eni lektini kao novo sredstvo
za istra`ivanje glikokonjugata
Sa`etak
Istra`ivanja provedena tijekom posljednjih godina nedvojbeno su pokazala da {e}erni
dijelovi glikokonjugata imaju mnoge bitne fiziolo{ke funkcije u vi{ih organizama. Budu}i
da je glikobiologija razmjerno nova znanost, a strukture {e}era vrlo slo`ene, potrebno je
trajno razvijati nove analiti~ke postupke koji }e unaprijediti spoznaje o zamr{enoj strukturi
i funkciji glikokonjugata. U ovom je radu opisano uvo|enje digoksina kao novog biljega
za lektine radi njihove primjene u analiti~kim postupcima, kao {to je »lectin-western blot«
ili histokemija. Lektini obilje`eni digoksinom imaju bitne prednosti pred onima obilje`e-
nim biotinom ili digoksigeninom i trebali bi biti korisni u glikobiolo{kim istra`ivanjima.
